| Literature DB >> 35284870 |
Patricia Zajaczkowski1, Rogan Lee2,3, Stephanie M Fletcher-Lartey4, Kate Alexander4, Abela Mahimbo5, Damien Stark6, John T Ellis1.
Abstract
Giardia intestinalis continues to be one of the most encountered parasitic diseases around the world. Although more frequently detected in developing countries, Giardia infections nonetheless pose significant public health problems in developed countries as well. Molecular characterisation of Giardia isolates from humans and animals reveals that there are two genetically different assemblages (known as assemblage A and B) that cause human infections. However, the current molecular assays used to genotype G. intestinalis isolates are quite controversial. This is in part due to a complex phenomenon where assemblages are incorrectly typed and underreported depending on which targeted locus is sequenced. In this review, we outline current knowledge based on molecular epidemiological studies and raise questions as to the reliability of current genotyping assays and a lack of a globally accepted method. Additionally, we discuss the clinical symptoms caused by G. intestinalis infection and how these symptoms vary depending on the assemblage infecting an individual. We also introduce the host-parasite factors that play a role in the subsequent clinical presentation of an infected person, and explore which assemblages are most seen globally.Entities:
Keywords: Assemblages; Giardiasis; Molecular biology; Typing; Zoonotic potential
Year: 2021 PMID: 35284870 PMCID: PMC8906113 DOI: 10.1016/j.crpvbd.2021.100055
Source DB: PubMed Journal: Curr Res Parasitol Vector Borne Dis ISSN: 2667-114X
Common molecular methods used for genotyping Giardia intestinalis assemblages A and B
| Loci targeted for genotyping | Genotyping method | Name of primer/probe | Primer or probe sequence (5′-3′) | Amplicon size (bp) | Specificity | Reference |
|---|---|---|---|---|---|---|
| SSU rRNA | Multiplex real-time (Scorpion) PCR | ScA | Probe (HEX-CCCGGCGCATGGCTTCGTCCTTGCCGGG-BHQ1-HEG-ATCCTGCCGGAGCGCGACG) | – | A & B | |
| ScB | Probe (FAM-CGGGCATGCATGGCCCG-BHQ1-HEG-CGGTCGATCCTGCCGGAATC) | – | ||||
| SSU rRNA | Nested PCR and sequencing | Primary: r37fw | CAAGGACRMAAGCCATGC | 847 | A & B | |
| Secondary: r275fw | GGAGRATCAGGGTTYGACTC | 506 | ||||
| SSU rRNA | Nested PCR and sequencing | Primary: RH11 | CATCCGGTCGATCCTGCC | 292 | A & B | |
| Secondary: GiarF | GACGCTCTCCCCAAGGAC | 130 | ||||
| Single and/or nested-PCR-RFLP | Primary: G7 | AAGCCCGACGACCTCACCCGCAGTGC | 753 | A & B | ||
| Secondary: BGiF/G99 | GAACGAGATCGAGGTCCG | 511 | ||||
| RE: | – | 50, 113, 150, 200 (A); 24–26, 84, 113–117, 150 (B) | ||||
| Semi-nested PCR-RFLP | Primary: GDHeF | TCAACGTYAAYCGYGGYTTCCGT | – | A (AI, AII) & B (BIII, BIV) | ||
| Secondary: GDHiF | CAGTACAACTCYGCTCTCGG | 432 | ||||
| RE: | – | – | ||||
| Nested PCR and sequencing | Primary: Gdh1 | TTCCGTRTYCAGTACAACTC | 754 | A (AI, AII, AIII) & B (BIII, BIV) | ||
| Secondary: Gdh3 | ATGACYGAGCTYCAGAGGCACGT | 530 | ||||
| Nested-PCR and/or assemblage-specific PCR | Primary: AL3543 | AAATIATGCCTGCTCGTCG | 605 | A & B | ||
| Secondary: AL3544 | CCCTTCATCGGIGGTAACTT | 532 | ||||
| Assemblage A-specific primers | ||||||
| Af | CGCCGTACACCTGTCA | 332 (A) | ||||
| Assemblage B-specific primers | ||||||
| Bf | GTTGTTGTTGCTCCCTCCTTT | 400 (B) | ||||
| Semi-nested PCR and sequencing | Primary: tpi1f | CCCTTCATCGGYGGTAAC | – | A (AI, AII) & B (BIII, BIV) | ||
| Secondary: tpi300r | AGRGCACGCTTMGCCTTC | 339 | ||||
| Semi-nested, duplex PCR | Assemblage A-specific primers | A (AI, AII) & B | ||||
| Primary: TPIA-F | CGAGACAAGTGTTGAGATGC | 576 (A) | ||||
| Secondary: TPIA-IF | CCAAGAAGGCTAAGCGTGC | 476 (A) | ||||
| Assemblage B-specific primers | ||||||
| Primary: TPIB-F | GTTGCTCCCTCCTTTGTGCA | 208 (B) | ||||
| Secondary: TPIB-IF | GCACAGAACGTGTATCTGG | 140 (B) | ||||
| RE: | – | 437, 39 (AI); 235, 202, 39 (AII) | ||||
| PCR-RFLP | Forward primer | TGGACTGGCGAGACAAG | 540 | A & B | ||
| RE: | – | 540 (A); 442, 241 (B) | ||||
| Real-time (TaqMan-MGB) PCR | GDAT | Probe (VIC-CCATTGCGGCAAACA-MGB-NFQ) | – | A & B | ||
| GDBT | Probe (FAM-AATATTGCTCAGCTCGAG-MGB-NFQ) | – | ||||
| Assemblage-specific PCR | Assemblage A-specific primers | A & B | ||||
| 4E1-HP-AF | AAAGAGATAGTTCGCGATGTC | 165 (A) | ||||
| Assemblage B-specific primers | ||||||
| 4E1-HP-BF | GAAGTCATCTCTGGGGCAAG | 272 (B) | ||||
| Real-time PCR-HMC | TIF-assemblage AF | AGAAGTGTCCTGGACTGGGTCT | 168 (A) | A & B | ||
| CATH-assemblage BF | GCGATTTTCCGCGGAAGGTTGT | 99 (B) | ||||
| IGS region of rDNA | Nested PCR -gel electrophoresis | Primary: GLF | GACCGTCGTGAGACAGGTTAG | – | A (AI, AII) & B | |
| Assemblage AI-specific primers | ||||||
| GA1F | GGTTTGCCGTGATATGCA | 176 (AI) | ||||
| Assemblage AII-specific primers | ||||||
| GA2F | CCCTCCAGAGCAGMRTGAGA | 261 (AII) | ||||
| Assemblage B-specific primers | ||||||
| GBF | GRCAGGTGTGCTCAGGTG | 319 (B) | ||||
| IGS region of rDNA | Real-time PCR-HMC | Primers as listed above (GLF, GSR, GA1F, GA2F, GBF and GABR) | – | – | A (AI, AII) & B | |
| Real-time PCR | Assemblage A-specific primers | A & B | ||||
| ORFC4-AF | CTGTAGACAGGGCCCAGGCC | 103 (A) | ||||
| TPI-AF | TCGTCATTGCCCCTTCCGCC | 77 (A) | ||||
| GDH-AF | CCGGCAACGTTGCCCAGTTT | 180 (A) | ||||
| Assemblage B-specific primers | ||||||
| ORFC4-BF | ACTGTCCATTTCTATCTGAG | 171 (B) | ||||
| TPI-BF | GATGAACGCAAGGCCAATAA | 77 (B) | ||||
| GDH-BF | CGTATTGGCGTCGGCGGT | 133 (B) | ||||
| MLST-PCR -sequencing | As listed above | As listed above | A (AI, AII, AIII) & B (BIII, BIV) | |||
| SSU rRNA primers: RH11, RH4, GiarF, GiarR |
tpi, triosephosphate isomerase; gdh, glutamate dehydrogenase; bg, β-giardin; SSU rRNA, small subunit ribosomal ribonucleic acid; IGS, intergenic spacer; Tif, translation initiation factor gene; Cath, cathepsin L precursor gene.
PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; MLST, multilocus sequence typing; HMC, high resolution melting curve analysis.
In this paper, MLST refers to genotyping that has amplified sequences at three or more loci: tpi, gdh, bg and SSU rRNA.
Associations seen between Giardia assemblages and clinical symptoms
| Country | Study outline and sample size | Locus targeted | Genotypes detected (%) | Symptoms observed and assemblage associations | Reference |
|---|---|---|---|---|---|
| Australia | Children aged under 5 years and attending day-care centres. | SSU-rRNA | Assemblage A (30%) | Children infected with assemblage A were 26 times more likely to have diarrhoea ( An association was also found between assemblage B and asymptomatic infection in children less than 5 years of age. | |
| Bangladesh | Patients with diarrhoea admitted to a research institution ( | SSU-rRNA | Symptomatic cases ( Asymptomatic cases ( | 7 times more likely to have diarrhoea with an assemblage A infection (OR = 6.88; Assemblage B infection was statistically associated with asymptomatic infection and occurred at a significant rate in the population (18.0%; | |
| Stool samples collected from diarrhoeal and non-diarrhoeal patients and genotyped by qPCR ( | SSU-rRNA | Diarrhoeal cases ( Non-diarrhoeal cases ( | Strong association between diarrhoea and assemblage A infection ( Assemblage B infection was associated with non-diarrhoeal, asymptomatic infections ( | ||
| Brazil | Stool specimens collected from 47 children at 3-month intervals and during diarrhoeal episodes ( | SSU-rRNA | Assemblage A (16%) | No significant difference in diarrhoeal symptoms experienced. | |
| Cuba | Assemblage A (45%) | Significant association between | |||
| Assemblage A (25%) | Significant association between diarrhoea and assemblage B infection ( | ||||
| Egypt | Samples acquired from school children ranging in age from 5 to 15 years. | IGS region rDNA | Symptomatic cases ( Asymptomatic cases ( | Sub-assemblage AI was less common in symptomatic children as opposed to asymptomatic children (53.3 Sub-assemblage AII was only reported among asymptomatic children. There was a significant relationship between symptomatic children and assemblage B ( | |
| Samples collected from patients (aged 2–55 years-old) complaining of diarrhoea ( | Assemblage A (37%) | Cases infected with assemblage A were significantly more likely to report severe and recurring diarrhoea ( | |||
| England | Patients with gastroenteritis and a | Assemblage A (31%) | Cases infected with assemblage B were significantly more likely to report vomiting ( | ||
| Ethiopia | Assemblage A (52%) | Significant association between nausea, abdominal pain, diarrhoea, and assemblage B infection (OR = 12; | |||
| India | Children living in a community birth cohort with giardial diarrhoea ( | Symptomatic cases ( Asymptomatic cases ( | Association between diarrhoea and assemblage A infection ( | ||
| Iran | Faecal samples collected from individuals referred to medical laboratories. Genotyping was performed on ( | Assemblage A (52%) | No significant association was observed between assemblages and clinical manifestations. | ||
| Assemblage A (74%) | Significant association between assemblage AII and abdominal pain, nausea, and vomiting. | ||||
| Voluntary participants from rural and urban communities. A total of 24 | Assemblage A (50%) | No significant association was observed between assemblages and clinical manifestations. | |||
| Human stool samples gathered from individuals admitted to medical and health care facilities. Twenty-three samples were successfully genotyped ( | Assemblage A (78%) | No significant association was observed between assemblages and clinical manifestations. | |||
| Malaysia | Indigenous individuals living in village communities ( | SSU-rRNA | Assemblage A (2%) | Two times more likely to have diarrhoea, abdominal pain, vomiting and nausea with an assemblage B infection (OR = 2.4; | |
| Nicaragua | Human stool samples from diarrhoeal patients and healthy individuals ( | Assemblage A (21%) | No association was observed between symptoms experienced and assemblage type. | ||
| Portugal | Asymptomatic individuals including adults and children under 12 years of age ( | Assemblage A (29%) | Asymptomatic infections seen in individuals infected with assemblages A and B. | ||
| Saudi Arabia | Primary-school children aged 6–12 years ( | IGS region rDNA | Symptomatic cases ( Asymptomatic cases ( | Symptomatic giardiasis was significantly associated with assemblage B (OR = 25.874; | |
| Spain | Patients with symptomatic or asymptomatic giardiasis ( | Assemblage A (40%) | Significant association between symptomatic infections and assemblage A ( A significant association was also found between asymptomatic infections and assemblage B ( These correlations were only significant in children 5 years-old and younger. | ||
| Samples collected from out-patients (aged 1–75 years) from multiple hospitals ( | Assemblage A (30%) | Significant association between asymptomatic infection and assemblage A (OR = 10.4; Frequency of abdominal pain occurrence was higher in assemblage B patients (98.5 | |||
| Sweden | Patients with intestinal symptoms who consulted a physician and individuals who attended health check-ups ( | Assemblage A (35%) | Correlation between flatulence and assemblage B infections in children aged 6 years and younger ( | ||
| Syria | Samples collected from three main hospitals. Forty patients with symptomatic giardiasis participated in the study ( | Assemblage A (67.5%) | Significant association between weight loss and sub-assemblage AII ( | ||
| Thailand | Assemblage A (8%) | All assemblage A infections were symptomatic; however, there was no significant association between assemblages and symptomatic giardiasis. | |||
| Turkey | Samples from patients with symptomatic/asymptomatic giardiasis were included in the study ( | Stool specimens ( Duodenal aspirates ( | Strong association between diarrhoeal symptoms and assemblage A infection (17 out of 20 isolates; Majority of asymptomatic infections are associated with assemblage B (22 out of 24 isolates). | ||
| United Arab Emirates | Assemblage A (45.7%) | Strong association between the presence of diarrhoea and assemblage B infection (OR = 10.533; An association was also found between mixed infections (A+B) and diarrhoea (OR = 8.899; | |||
| United Kingdom | Assemblage A (24%) | Fever was significantly more common in assemblage A infections (OR = 5.091; Longer illness or asymptomatic infection was linked with assemblage B infection; however, this was not statistically significant. |
This result was more significant when mixed assemblage cases (A and B) and mixed intestinal infections were excluded from the analysis.
This result was only significant when mixed intestinal infections were excluded from the analysis.